ITRM20020109A1 - Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. - Google Patents

Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.

Info

Publication number
ITRM20020109A1
ITRM20020109A1 IT2002RM000109A ITRM20020109A ITRM20020109A1 IT RM20020109 A1 ITRM20020109 A1 IT RM20020109A1 IT 2002RM000109 A IT2002RM000109 A IT 2002RM000109A IT RM20020109 A ITRM20020109 A IT RM20020109A IT RM20020109 A1 ITRM20020109 A1 IT RM20020109A1
Authority
IT
Italy
Prior art keywords
pentraxin
cancers
prepare
treatment
functional derivatives
Prior art date
Application number
IT2002RM000109A
Other languages
English (en)
Italian (it)
Inventor
Santis Rita De
Giovanni Salvatori
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2002RM000109A priority Critical patent/ITRM20020109A1/it
Publication of ITRM20020109A0 publication Critical patent/ITRM20020109A0/it
Priority to TW092103564A priority patent/TWI293958B/zh
Priority to PL03372719A priority patent/PL372719A1/xx
Priority to CA002475526A priority patent/CA2475526A1/en
Priority to AU2003214645A priority patent/AU2003214645A1/en
Priority to JP2003571309A priority patent/JP2005538690A/ja
Priority to PCT/IT2003/000104 priority patent/WO2003072603A2/en
Priority to MXPA04008217A priority patent/MXPA04008217A/es
Priority to KR10-2004-7013464A priority patent/KR20040099291A/ko
Priority to EP03710225A priority patent/EP1478661A2/en
Priority to US10/506,046 priority patent/US20090110666A1/en
Priority to ARP030100642A priority patent/AR038854A1/es
Publication of ITRM20020109A1 publication Critical patent/ITRM20020109A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT2002RM000109A 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. ITRM20020109A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
TW092103564A TWI293958B (en) 2002-02-28 2003-02-20 Functional derivatives of the long pentraxin ptx3 for the preparation of an autologous vaccine for the treatment of tumours
US10/506,046 US20090110666A1 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
AU2003214645A AU2003214645A1 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
CA002475526A CA2475526A1 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
PL03372719A PL372719A1 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
JP2003571309A JP2005538690A (ja) 2002-02-28 2003-02-25 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体
PCT/IT2003/000104 WO2003072603A2 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
MXPA04008217A MXPA04008217A (es) 2002-02-28 2003-02-25 Derivados funcionales de pentraxin ptx3 grandes para preparar vacuna autologa para tratamiento de tumores.
KR10-2004-7013464A KR20040099291A (ko) 2002-02-28 2003-02-25 종양 치료용 자가이식성 백신의 제조를 위한 긴 펜트락신ｐｔｘ３ 작용성 유도체
EP03710225A EP1478661A2 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
ARP030100642A AR038854A1 (es) 2002-02-28 2003-02-27 Derivados funcionales de la pentraxina larga ptx3 para la preparacion de una vacuna autologa para el tratamiento de tumores

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.

Publications (2)

Publication Number Publication Date
ITRM20020109A0 ITRM20020109A0 (it) 2002-02-28
ITRM20020109A1 true ITRM20020109A1 (it) 2003-08-28

Family

ID=11456119

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.

Country Status (12)

Country Link
US (1) US20090110666A1 (enExample)
EP (1) EP1478661A2 (enExample)
JP (1) JP2005538690A (enExample)
KR (1) KR20040099291A (enExample)
AR (1) AR038854A1 (enExample)
AU (1) AU2003214645A1 (enExample)
CA (1) CA2475526A1 (enExample)
IT (1) ITRM20020109A1 (enExample)
MX (1) MXPA04008217A (enExample)
PL (1) PL372719A1 (enExample)
TW (1) TWI293958B (enExample)
WO (1) WO2003072603A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040858A1 (it) 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
SI1973944T1 (sl) * 2006-01-24 2016-07-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. FGF2 vezavni peptidi in njihova uporaba
US9226960B2 (en) 2010-04-16 2016-01-05 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
US8435525B1 (en) * 2010-04-16 2013-05-07 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
TWI531375B (zh) 2015-05-29 2016-05-01 國立成功大學 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) * 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20020122820A1 (en) * 2001-01-16 2002-09-05 Hildebrand William H. Soluble MHC artificial antigen presenting cells
AU2002324328B2 (en) * 2001-08-03 2007-09-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of long pentraxin PTX3 for treating female infertility
US7041648B2 (en) * 2001-08-03 2006-05-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compositions and methods for treating female fertility
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
US20070023879A1 (en) * 2005-07-29 2007-02-01 Vinayak Pandey Single unit heat sink, voltage regulator, and package solution for an integrated circuit

Also Published As

Publication number Publication date
TW200303755A (en) 2003-09-16
EP1478661A2 (en) 2004-11-24
WO2003072603A2 (en) 2003-09-04
PL372719A1 (en) 2005-07-25
CA2475526A1 (en) 2003-09-04
WO2003072603A3 (en) 2004-03-18
US20090110666A1 (en) 2009-04-30
AR038854A1 (es) 2005-01-26
MXPA04008217A (es) 2004-11-26
WO2003072603A9 (en) 2004-10-07
AU2003214645A1 (en) 2003-09-09
AU2003214645A8 (en) 2003-09-09
KR20040099291A (ko) 2004-11-26
ITRM20020109A0 (it) 2002-02-28
TWI293958B (en) 2008-03-01
JP2005538690A (ja) 2005-12-22

Similar Documents

Publication Publication Date Title
CY1111757T1 (el) Παραγωγα ξανθινης ως εκλεκτικοι αναστολεις ημ74α
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
CY1107426T1 (el) Νεα παραγωγα φθοριογλυκοσιδιων απο πυραζολες, φαρμακευτικα προϊοντα που περιεχουν τις εν λογω ενωσεις και η χρηση αυτων
NO20053530L (no) Multivalente lymfotoksin-beta-reseptorantagonister samt anvendelse derav
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
NO20042576L (no) Nikotin, eller isonikotinbenzotiazolderivater
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
DK1549283T3 (da) Merocyanine derivatives for cosmetic use
HN2008000949A (es) Derivados de pirimidinil- aril- urea que son inhibidores de fgf
ES2572454T3 (es) Tratamiento de enfermedades mediadas por los linfocitos T
BRPI0313733A8 (pt) Uso da proteína n beta cinase
DK1453517T3 (da) Farmaceutiske formuleringer med platinderivat
CY1106726T1 (el) Υποκατεστημενα βενζοπυρανια ως επιλεκτικοι συναγωνιστες οιστρογονικου υποδοχεα β
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ITRM20020109A1 (it) Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
AR046672A1 (es) Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol
SE0300457D0 (sv) Novel compounds
BRPI0607413A2 (pt) composição farmacêutica compreendendo derivados de indolilmaleimida
ITMI20030312A1 (it) Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer.
ITMI20001869A0 (it) Procedimento per la preparazione di derivati della baccatina iii
ITMI20020597A1 (it) Derivati del probucolo
BR0204228A (pt) Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico
ITRM20020191A1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
BRPI0417968A (pt) dispositivo de fornecimento para lámpadas ultravioletas utilizadas no tratamento de água